Physician profile
Shannon Soper
NPI 1215323464
$2,526.86
in general payments reported to CMS, 2019-2025
10 companies · $882 in 2025
The $882 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $59.28 · 2021: $233 · 2022: $392 · 2023: $213 · 2024: $596 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $728.81 | 2022-2025 | Infuse, Vyzulta, Biotrue One Day |
| Glaukos Corporation | $494.31 | 2022-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Sun Pharmaceutical Industries INC. | $449.39 | 2020-2025 | Cequa |
| Coopervision INC. | $233.63 | 2019-2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $196.57 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $131.42 | 2021 | |
| Lkc Technologies, INC. | $131.37 | 2025 | |
| Alcon Vision LLC | $90.92 | 2023-2025 | Total30, Eysuvis |
| Rxsight INC | $57.25 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Shire North American Group INC | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Soper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.